Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

Stocks - Mylan, Uber Rise Premarket; Pfizer, Domino’s Fall

Published 07/29/2019, 08:22 AM
Updated 07/29/2019, 08:26 AM
© Reuters.
DBKGn
-
AMZN
-
PFE
-
VTRS
-
EXAS
-
GHDX_old
-
DPZ
-
NVS
-
SNY
-
UBER
-

Investing.com - Stocks in focus in premarket trading on Monday:

• Mylan (NASDAQ:MYL) stock jumped 14.5% in premarket trade by 8:20 AM ET (12:20 GMT) after reports that it is planning to merge with Pfizer's off-patent drug business in an all-stock deal.

• Separately, Pfizer (NYSE:PFE) stock fell 2.3% after it lowered its full-year guidance, even as its earnings came in more than expected for the second-quarter.

• Uber (NYSE:UBER) stock rose 1% after Business Standard reported that Amazon (NASDAQ:AMZN) is in early stages to acquire Uber Eat’s business in India.

• Novartis (NYSE:NVS) stock slipped 1.1% after its heart failure drug Entresto did not meet its trial goal.

• Domino’s Pizza (NYSE:DPZ) stock declined 2% after Deutsche Bank (DE:DBKGn) initiated coverage at sell due to the competition presented by delivery companies, according to CNBC.

Sanofi (NASDAQ:SNY) stock jumped 2.8% after it raised its outlook for the year on strong second-quarter results. The French drugmaker reported earnings per share of €1.31 ($1.46) on €8.6 billion ($9.5 billion) revenue.

• EXACT Sciences (NASDAQ:EXAS) stock slumped 4.6% after it said it would buy healthcare company Genomic Health (NASDAQ:GHDX) for $2.8 billion to support its cancer testing business. Genomic was up 2.2%.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.